Status:
RECRUITING
Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast Cancer
Lead Sponsor:
Ankara Oncology Research and Training Hospital
Conditions:
Metastatic Breast Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
Locoregional (LRT) of the primary tumor in de-novo metastatic breast cancer (dnMBC) is no longer only a surgical challenge, but more the final decision of a multidisciplinary tumor board including med...
Detailed Description
Five to eight percent of breast cancer (BC) patients present with distant metastasis at diagnosis which is known as 'de novo' metastatic breast cancer (dnMBC). These patients represent up to 25% of al...
Eligibility Criteria
Inclusion
- Primary breast tumor amenable for complete surgical resection, patients in good physical condition for receiving protocol driven locoregional and systemic treatments and receiving radiotherapy.
Exclusion
- Primary tumor not amenable for complete resection; primary tumor with extended infection, bleeding, or necrosis; patients with poor physical condition which prevents the patient from receiving protocol driven locoregional and systemic treatment; synchronous primary cancer at the contralateral breast; clinically involved contralateral axillary nodes; patients not suitable for adequate follow-up, and failure to give informed consent. Pregnancy and lactation.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2028
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05334459
Start Date
March 1 2022
End Date
March 31 2028
Last Update
April 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lutfi Dogan
Ankara, Turkey (Türkiye)